白介素1受体拮抗剂(IL1RA)活性蛋白
Active Interleukin 1 Receptor Antagonist (IL1RA)
IL1RN; IL1-RA; ICIL1RA; IL1ra3; IL1F3; IRAP;IL-1RA; Interleukin-1 Family Member 3; IL1 inhibitor; Anakinra
- 编号APA223Hu61
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 缓冲液成份磷酸盐缓冲液(pH7.4,含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
- 性状冻干粉
- 纯度> 95%
- 等电点5.4
- 应用Cell culture; Activity Assays.
- 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1296 ¥ 3240 ¥ 6480 ¥ 19440 ¥ 48600
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
活性实验

IL-1RA is an agent that binds non-productively to the cell surface interleukin-1 receptor (IL-1R), the same receptor that binds interleukin 1 (IL-1), preventing IL-1 from sending a signal to that cell. Besides, Interleukin 1 Alpha (IL-1a) has been identified as an interactor of IL-1RA, thus a binding ELISA assay was conducted to detect the interaction of recombinant human IL-1RA and recombinant human IL-1a. Briefly, IL1RA were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100μL were then transferred to IL-1a-coated microtiter wells and incubated for 2 h at 37℃. Wells were washed with PBST and incubated for 1 h with anti-IL-1RA pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50µL stop solution to the wells and read at 450nm immediately. The binding activity of IL-1RA and IL-1a was shown in Figure 1, and this effect was in a dose dependent manner.
Figure. The binding activity of IL-1RA with IL-1a.
用法
Reconstitute in 10mM PBS (pH7.6) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
APA223Hu01 | 白介素1受体拮抗剂(IL1RA)活性蛋白 | Cell culture; Activity Assays. |
RPA223Hu01 | 白介素1受体拮抗剂(IL1RA)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA223Hu61 | 白介素1受体拮抗剂(IL1RA)活性蛋白 | Cell culture; Activity Assays. |
EPA223Hu61 | 白介素1受体拮抗剂(IL1RA)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA223Hu01 | 白介素1受体拮抗剂(IL1RA)多克隆抗体 | WB; IHC; ICC; IP. |
PAA223Hu06 | 白介素1受体拮抗剂(IL1RA)多克隆抗体 | WB; IHC; ICC; IP. |
LAA223Hu71 | 白介素1受体拮抗剂(IL1RA)多克隆抗体(生物素标记) | WB; IHC; ICC. |
LAA223Hu81 | 白介素1受体拮抗剂(IL1RA)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
MAA223Hu26 | 白介素1受体拮抗剂(IL1RA)单克隆抗体 | WB; IHC; ICC; IP. |
MAA223Hu22 | 白介素1受体拮抗剂(IL1RA)单克隆抗体 | WB; IHC; ICC; IP. |
MAA223Hu24 | 白介素1受体拮抗剂(IL1RA)单克隆抗体 | WB; IHC; ICC; IP. |
MAA223Hu25 | 白介素1受体拮抗剂(IL1RA)单克隆抗体 | WB; IHC; ICC; IP. |
MAA223Hu21 | 白介素1受体拮抗剂(IL1RA)单克隆抗体 | WB; IHC; ICC; IP. |
MAA223Hu23 | 白介素1受体拮抗剂(IL1RA)单克隆抗体 | WB; IHC; ICC; IP. |
LAA223Hu72 | 白介素1受体拮抗剂(IL1RA)单克隆抗体(生物素标记) | WB; IHC; ICC. |
HEA223Hu | 白介素1受体拮抗剂(IL1RA)检测试剂盒(酶联免疫吸附试验法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SEA223Hu | 白介素1受体拮抗剂(IL1RA)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA223Hu | 白介素1受体拮抗剂(IL1RA)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
PSA223Hu01 | 白介素1受体拮抗剂(IL1RA)抗体对 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSA223Hu01 | 白介素1受体拮抗剂(IL1RA)检测试剂盒DIY材料(酶联免疫吸附试验法) | 自己动手制作ELISA试剂盒的主要材料 |
参考文献
杂志 | 参考文献 |
The Veterinary Journal | Mucosal imbalance of interleukin-1β and interleukin-1 receptor antagonist in canine inflammatory bowel disease [ScienceDirect: S1090023312000962] |
Daily quercetin supplementation over a period of two weeks results in a moderate accumulation of total plasma flavonols in horses [Researchgate:Source] | |
Journal of Equine Veterinary Science | Synovial Fluid and Serum Concentrations of Interleukin-1 Receptor Antagonist and Interleukin-1 [Science: Article] |
Journal of Equine Veterinary Science | A Two-Week Quercetin Supplementation in Horses Results in Moderate Accumulation of Plasma Flavonol Concentrations [Science: Article] |
Scientific publications in peer reviewed journals | Evidence-based review of efficacy and adverse effects of joint medication and evaluation of synovial fluid and serum markers for osteoarthritis in the horse [receive:101658] |
Multiple Sclerosis and Related Disorders | Interleukin 1 receptor antagonist and 2′-5′-oligoadenylate synthetase-like molecules as novel biomarkers for multiple sclerosis patients in Bahrain [pubmed:29141788] |
Advances in Medical Sciences | A similar pro/anti-inflammatory cytokine balance is present in the airways of competitive athletes and non-exercising asthmatics [pubmed:28822267] |
Archives of Medical Research | Winter ambient training conditions are associated with increased bronchial hyperreactivity and with shifts in serum innate immunity proteins in young … [Pubmed:29379533] |
Journal of Veterinary Internal Medicine | Effect of interleukin‐1β on occludin mRNA expression in the duodenal and colonic mucosa of dogs with inflammatory bowel disease [Pubmed:29572935] |
Frontiers in Pharmacology | M10, a Myricetin-3-ObD-Lactose Sodium Salt, Prevents Ulcerative Colitis Through Inhibiting Necroptosis in Mice [Pubmed: 33041798] |